Jupiter Topco LLC Invests $43.72 Million in Septerna, Inc. $SEPN

Key Points

• Jupiter Topco LLC acquired 1.31 million Septerna shares worth approximately $43.7 million, giving it a 2.8% stake. Several other institutional investors also initiated positions during the second quarter.
• Septerna’s latest quarterly results exceeded expectations, with a loss of $0.29 per share versus the $0.43 consensus estimate and revenue of $26.75 million versus $19.22 million expected.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $52.44 target price, although insiders sold 61,030 shares worth about $2.33 million during the last quarter.

Jupiter Topco LLC bought a new stake in Septerna, Inc. (NASDAQ:SEPN - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,307,500 shares of the company's stock, valued at approximately $43,723,000. Jupiter Topco LLC owned approximately 2.80% of Septerna as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of SEPN. Elmind Capital LP purchased a new position in Septerna in the second quarter worth about $1,655,880,000. ADAR1 Capital Management LLC bought a new stake in shares of Septerna in the 2nd quarter valued at approximately $31,506,000. Primecap Management Co. CA purchased a new position in shares of Septerna in the 2nd quarter worth approximately $39,096,000. Canada Pension Plan Investment Board bought a new position in shares of Septerna during the 2nd quarter valued at approximately $298,000. Finally, Legal & General Group Plc purchased a new stake in Septerna during the 2nd quarter valued at $337,000.

Septerna Trading Up 0.5%

SEPN opened at $40.47 on Friday. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of -74.94 and a beta of 2.29. Septerna, Inc. has a 12-month low of $11.70 and a 12-month high of $51.10. The business's fifty day simple moving average is $37.24 and its 200-day simple moving average is $30.75.

Septerna (NASDAQ:SEPN - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.43) by $0.14. Septerna had a negative return on equity of 9.57% and a negative net margin of 24.51%.The firm had revenue of $26.75 million during the quarter, compared to the consensus estimate of $19.22 million. On average, equities research analysts predict that Septerna, Inc. will post -1.41 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Septerna in a research note on Friday, July 17th. Raymond James Financial reissued a "strong-buy" rating and set a $49.00 price target on shares of Septerna in a research note on Tuesday, August 11th. JonesTrading boosted their price objective on Septerna from $43.00 to $62.00 and gave the company a "buy" rating in a report on Thursday, August 13th. Wells Fargo & Company upped their price objective on Septerna from $48.00 to $50.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Finally, Truist Financial increased their target price on Septerna from $35.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, July 1st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $52.44.

Insider Buying and Selling at Septerna

In other news, insider Samira Shaikhly sold 6,250 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $35.08, for a total transaction of $219,250.00. Following the transaction, the insider directly owned 793 shares in the company, valued at approximately $27,818.44. This trade represents a 88.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Daniel D. Long sold 15,000 shares of Septerna stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $35.51, for a total transaction of $532,650.00. Following the transaction, the senior vice president directly owned 96,412 shares in the company, valued at approximately $3,423,590.12. The trade was a 13.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 61,030 shares of company stock valued at $2,329,666. Company insiders own 5.80% of the company's stock.

Septerna Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source